Senior White House adviser Anita Dunn counts pharmaceutical giant Pfizer as a former client, according to a recently released ethics disclosure.
Dunn is a senior adviser to President Joe Biden and managing director of SKDKnickerbocker, a public affairs and political consulting firm that has forged connections with major political figures within the Democratic Party.
Dunn, who also served as a former senior adviser and White House communications director during the Obama administration, returned to the White House as an assistant and senior adviser to the president in May, which meant she was required by law to file a public disclosure form.
Under “other assets and income,” Dunn also lists Pfizer, and states that it has a value of $1,001 – $15,000, although the income amount states “None (or less than $201).”
Sizeable Investment Portfolio
The 93-page financial disclosure document also shows that Dunn did consulting work for the D.C.–based renewables trade group American Clean Power Association; Pivotal Ventures, an investment and incubation company founded by Melinda French Gates; and the Center for American Progress Action, a liberal public policy research and advocacy organization.The couple’s portfolio also includes at least $500,000 in a hedge fund.
Following the release of the recent disclosures, Jeff Hauser, executive director of the Revolving Door Project (RDP), a project of the Center for Economic and Policy Research (CEPR), questioned exactly what Dunn could work on in her role as a senior White House adviser on policy issues due to various ethics issues.
Ethical Issues
“What’s left? If the White House is taking its ethical obligations seriously and recusing Dunn from all policy areas where she has money in the game, well, what will she even be doing?”Hauser also noted that Dunn was previously considered a special government employee during her last posts at the White House and was thus able to avoid filing a public disclosure.
“This only underscores our concerns from Dunn’s two previous tours through the White House, when she tiptoed around disclosure laws and ethics pledges by only serving as a Special Government Employee. Now that she’s finally filed a disclosure, we know she received consulting income from Pfizer,” Hauser said.
“She previously advised the President during the COVID-19 vaccination boost early in his Presidency. How is remotely okay for a company making billions on government orders of its vaccine to get political and communications advice from a recent Presidential advisor, and then have that advisor head right back into the White House all while the pandemic rages on? This should be disclosed if it was going to happen, obviously, but the bigger issue is that it is happening at all.”
Dunn will divest from her and her husband’s investment portfolio and is recused from all matters involving SKDK and her past clients, White House spokesman Chris Meagher told CNBC in an email on Aug. 11. He said that Dunn won’t be allowed to attend any meetings involving those firms for two years.
White House and Pfizer spokespersons didn’t respond by press time to a request by The Epoch Times for comment.